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Abstract:  
Oxidation reactions are an important part of the synthetic organic chemist’s toolkit and 
continued advancements have, in many cases, resulted in high yields and selectivities. This 
review aims to give an overview of the current state-of-the-art in oxygenation reactions 
using both chemical and enzymatic processes, the design principles applied to date and a 
possible future in the direction of hybrid catalysts combining the best of chemical and 
natural design. 
 
Oxidation reactions are an important part of the synthetic organic chemist’s toolkit and 
have been known for over 160 years, with the oxidative properties of potassium 
permanganate reported in 1851.1 By the mid-20th Century it had also been established that 
nature conducts many redox reactions, and we now know that many biological processes 
from cellular respiration to photosynthesis are centered on redox reactions.2 Oxidation 
reactions such as the Sharpless epoxidation, Swern oxidation and ozonolysis enable 
chemists to perform a myriad of different transformations, and continued advancements 
have in many cases resulted in high yields and selectivities. This review aims to give an 
overview of the current state-of-the-art in oxygenation reactions using both chemical and 
enzymatic processes, the design principles applied to date, and a possible future in the 
direction of hybrid catalysts combining the best of chemical and natural design. 
 
1. Chemical oxidation 
 
One of the main challenges faced in the optimization of any type of reaction is controlling 
the selectivity. In oxidation chemistry, one quickly encounters the inherent difficulty in 
controlling the site-, chemo- and enantioselectivity. Frequently the initially formed oxidation 
products will be more susceptible to oxidation than the initial starting material,3 which 
renders chemoselectivity challenging. Alkane oxidation is prone to over-oxidation at 
multiple positions, to the extent that catalytic experiments are frequently performed with 
100 or even 1000 fold excess of the substrate to minimise over-oxidation to ketone, 
aldehyde and carboxylic acid side products.4,5 Each of these problems is further complicated 
by the presence of other oxidation-prone functional groups, which is a particular challenge 
for functionalities lacking efficient protecting group strategies (alkenes), or in C-H oxidation 
where multiple oxidation sites exist for many substrates. Another challenge facing the 
chemical industries is the desire to make processes as ‘green’ and economical as possible. 
Many oxidations rely on oxidants and co-oxidants, which are not atom economical, such as 
hypervalent iodine reagents. Catalytic oxidation employing O2 or H2O2 represents a great 
step forward, and exciting developments towards this have been reported.6  
 
The most common substrates for oxidation, in either academic or industrial contexts, are 
primary and secondary alcohols,7 sulfides,8 alkenes (employed both for epoxidation and 
dihydroxylation)9 and alkanes.10 Each substrate carries its own particular challenges for 
selective oxidation and we will discuss the most promising methods currently available to 
overcome these issues.  
 
 
1.1. Oxidation of alcohols 
 
There are a whole plethora of methods available to oxidize alcohols to the corresponding 
ketone, aldehyde or acid.11 The preferred oxidant in industry is TEMPO (2,2,6,6-tetramethyl-
1-piperidinyloxy), followed by procedures involving sulfur compounds (Swern Oxidation, 
Moffat or SO3.pyridine) or transition metal catalysis (e.g. Ley-Griffith oxidation
12) (Scheme 
1).11 These methods allow the oxidation of primary alcohols to be stopped at the 
intermediate aldehyde product rather than progressing further to carboxylic acid formation. 
More challenging is the oxidation of primary alcohols in the presence of secondary alcohols. 
This is illustrated nicely by work towards the selective oxidation of lignin.13 Lignin is a 
biopolymer that contains both primary and secondary alcohols and is an important potential 
renewable feedstock for aromatic chemicals.14,15 A model compound of lignin (1) was tested 
with a variety of oxidants and it was found that the oxidation of the benzylic alcohol can be 
obtained selectively with a variety of oxidants, even when applied on lignin itself. However, 
bleach in the presence of catalytic TEMPO was the only system resulting in the selective 
oxidation of the primary alcohol in 1 (Scheme 2).  
 
 
Scheme 1: The preferred choices for oxidation of primary and secondary alcohols.11 
  
Scheme 2: Selective oxidation of a lignin model compound.13 
 
The quest to improve atom efficiency has led to work focusing on the use of oxygen to 
oxidize alcohols. The most successful approach to date has been the use of catalytic 
TEMPO/metal systems under an aerobic atmosphere.7 The chemoselective oxidation of 
primary alcohols using Cu(I)/TEMPO or Cu(I)/ABNO (ABNO = 9-azabicyclo[3.3.1]nonane N-
oxyl radical) catalyst systems has been reported.16 This methodology tolerates other 
oxidizable functional groups such as alkenes, alkynes, heterocycles, thioethers, and aryl 
halides and can selectively oxidize diols (Scheme 3). A continuous-flow process provides full 
conversion of phenyl and alkynyl alcohols within 5 minutes with catalyst loadings as low as 
0.25 mol% copper.17 That this work has reached the level of process development on a 
research scale certainly reveals its promise for future large-scale application and the 
replacement of stoichiometric oxidants. 
 
 
 
Scheme 3: Cu(I)/ABNO system for selective alcohol oxidation with wide functional group 
tolerance (selected examples) (NMI = N-methylimidazole, MeOBpy = 4,4’-dimethoxy-2,2’-
bipyridine).16 
 
1.2. Asymmetric sulfoxidation 
 
Chiral sulfoxides have become highly desired compounds over the last 25 years due to their 
renowned bioactivity and their potential as chiral ligands for transition metals.8 Early 
methods of asymmetric sulfoxidation were based on the titanium catalysts used by 
Sharpless for epoxidation and were often limited to aryl methyl sulfides.18,19 One exception 
to this was the use of 2, the oxaziridine derivative of camphor, which gave good to excellent 
enantioselectivities for a range of aryl alkyl and aryl alkenyl sulfides (Scheme 4).20 
 
 
Scheme 4: Organocatalytic sulfoxidation of sulfides using oxaziridine, 2.20 
 
Ligand development has led to catalysts with broadened reaction scope.21 Of particular note 
are the Schiff base complexes reported by the groups of Bolm and Katsuki.  The vanadium 
complexes of Bolm are efficient catalysts for the oxidation of aryl alkyl sulfides (54-94% 
yield, up to 70% ee),22 thioacetals (Scheme 5) and disulfides.23 Katsuki has reported a variety 
of metal salen, salalen and salan complexes. Of these, the aluminium salalen complex 
Al(4)Cl has emerged as a state of the art reagent in the sulfoxidation of cyclic alkyl 
dithioacetals (Scheme 5).24 The conformational flexibility of the substrate is important in 
determining the selectivity of the reaction: acyclic dithioacetals delivered very low 
selectivities and yields relative to the cyclic substrates. Furthermore, di-sulfoxidation was 
difficult to avoid for several substrates, leaving room for further optimisation and 
broadening of substrate scope. Dialkyl and sterically hindered sulfides remain a challenge 
with catalysts suffering from poor activity.25 
 
 
Scheme 5: Vanadium and Al-salalen catalysts for highly selective oxidation of cyclic 
dithioacetals (acac = acetylacetonate).22,24 
 
1.3. Olefin epoxidation and dihydroxylation 
 
The use of epoxides and 1,2-diols in synthetic and industrial applications has led to the fast 
development of these transformations over the last 40 years. Classic reagents such as meta-
chloroperoxybenzoic acid (mCPBA) and H2O2 are still often the regents of choice when there 
is no requirement for regio- or enantioselectivity. The pioneering work of Sharpless and 
Katsuki in the early 1980s on asymmetric epoxidation of allyl alcohols led to the 
development of titanium catalysts derived from Ti(Oi-Pr)4 and either (+) or (-) diethyl 
tartrate (DET).26 This method is a gold standard in producing asymmetric epoxyalcohols 
using tert-butyl hydroperoxide, however it is limited to alkenes with directing groups such as 
alcohols.  Subsequent work by Jacobsen and Katsuki developed Mn(III) salen catalysts for a 
more general epoxidation of cis-disubstituted and trisubstituented alkenes.27,28 Meanwhile, 
Shi demonstrated the potential of organocatalysis in the epoxidation of terminal, cis- and 
trans-disubstituted, and trisubstituted alkenes (Figure 1).29  
 
Figure 1: Timeline of discoveries in epoxidation reactions.30,31,32 
The classic reagent for dihydroxylation is OsO4, and the use of N-methylmorpholine N-oxide 
(NMO) by Upjohn has rendered this methodology catalytic in osmium.33 The development of 
chiral cinchona alkaloid ligands, such as 10, by Sharpless provided the first breakthrough in 
asymmetric dihydroxylation (Scheme 6).34 Since then several modifications have been 
reported.35 Despite the high cost and toxicity of OsO4, catalytic osmium remains one of the 
most effective methods for carrying out this transformation. Although, osmium free-
approaches have been developed (Scheme 7)36, OsO4 remains the method of choice in 
natural product synthesis.37,38  
 
Scheme 6: Cis-dihydroxylation using Cinchona ligands.34 
 
 
Scheme 7: Conditions employed for cis and trans olefin dihydroxylation without OsO4.
36  
Recent advances in both epoxidation and dihydroxylation have focused on the use of 
hydrogen peroxide as a ‘green oxidant’ in conjunction with metal catalysts or 
organocatalysts.6 Whilst impressive results have been obtained that allow the 
enantioselective epoxidation and dihydroxylation of many alkenes, styrenes and 
symmetrical (or near symmetrical) alkenes remain challenging substrates. Other limitations 
to substrate scope include the requirement of a chelating or electron withdrawing activating 
group in the substrate for synthetically useful activity. Additionally, halogenated solvents 
are often used which is undesirable from an industrial standpoint.39  
 
Another approach worthy of mention for the synthesis of enantiopure epoxides is the 
development of hydrolytic kinetic resolution (HKR) using Co(II) salen catalysts to enable 
racemic mixtures of a terminal epoxide to be enriched in favour of one enantiomer, with the 
enantiopure hydrolysis product of the other enantiomer also being produced.40 More 
recently, enzymes such as galactose oxidase have been used in this manner (see Section 
2.3). Dynamic kinetic resolution offers a less wasteful method for procuring enantiopure 
epoxides but very few effective catalysts for this approach exist.41  
 
 
 1.4. Alkane oxidation 
 
The oxidation of C-H bonds is highly desirable, both as a way of generating platform 
chemicals from petrochemical feedstocks and for late-stage modification of complex 
molecules. The oxidation of methane and other alkanes has been the focus of intense 
research.42,43 The challenges to overcome are the chemical inertness of the C-H bond and 
overoxidation ultimately to CO2. The discovery by Shilov that Pt(II) could readily oxidize 
methane to methanol,44 and its subsequent optimization by Periana leading to the ‘Periana-
Catalytica’ system, illustrated that even the most inert chemical substrate of all could be 
selectively oxidized.45 In order to keep selectivity high and avoid overoxidation the product 
concentration must be kept below 1 M. Advancements have been made with the whole 
plethora of late-transition metal catalysts, however few of these catalysts have reached the 
activities and stabilities needed for general use.46,10 Heteropoly acids have also been 
extensively studied for alkane oxidation, but low yields (often less than 10%) and poor 
selectivities have hindered commercialization.47  
 
By contrast microporous solids have provided a number of more successful oxidation 
catalysts. The rigid framework of the material serves to restrict the conformational flexibility 
of the substrate at the active site, restricting oxidation to the least sterically hindered sites. 
The strength of this approach has been shown by Tolman’s Fe-Pd zeolite which is one of the 
best C-1 selective oxidation catalysts for n-octane to date with 67% selectivity for primary C-
H bonds over secondary C-H bonds.139  These results are particularly impressive considering 
that the catalyst operates via Fenton chemistry, which generates extremely reactive 
hydroxyl radicals, as opposed to the more selective metal-oxo type mechanism. Radical 
reactions show a preference for C-H bonds with lower bond dissociation energies (BDE 
3o<2o<1o), though more reactive radicals, such as hydroxyl radicals, give lower selectivities 
(e.g. low 3o:2o ratios for the hydroxylation of alkanes such as adamantane).  A manganese 
zeolite reported by Iglesia and co-workers achieved primary selectivity of 42% in the 
oxidation of n-hexane.48 
 
 
Figure 2: Examples of late stage oxidation of complex molecules.49,52 
 
Arguably greater success has been experienced in the oxidation of more complex molecules 
(Figure 2).50 Both organic oxidants and metal complexes (especially iron, Scheme 8) in 
conjunction with oxidants such as H2O2 have successfully been used to oxidize a wide range 
of structurally complex substrates in moderate yields, but with high regio- and 
chemoselectivity.49,52 Both radical and metal-oxo mechanisms have been proposed for the 
iron catalysts used to date.42 Subtle ligand tuning effects are observed to change to change 
selectivities, for example the alcohol to ketone ratios of aliphatic C-H bonds or the 3o/2o 
selectivitiy in adamantane.51 The catalyst Fe(PDP) 11 appears to follow the selectivity 
expected of radical or electrophilic intermediates, as tertiary positions are oxidized to 
alcohols in preference to secondary C-H bonds (which are often oxidized all the way to 
ketones), and electron rich positions are favoured over electron deficient sites. This catalyst 
operates on the basis of substrate control, with selectivity predicted on the basis of each 
substrate’s steric, electronic and stereoelectronic properties.52 White and co-workers have 
shown that increasing the steric bulk of the PDP ligand (seen in 11, Scheme 8) by adding 2,6-
(CF3)Ph groups in the ortho position leads towards reactions proceeding under catalyst 
control, and therefore overrides some of the innate substrate control.53 The results 
obtained to date are impressive, though in many cases the yields are only moderate and 
simpler substrates such as alkanes undergo low conversion even when used in excess. On 
more complex substrates, predictable late stage functionalization of C-H bonds adds a 
powerful tool to the synthetic chemist’s arsenal. Despite encouraging breakthroughs, 
combining high selectivity with synthetically relevant activity remains elusive in this field, 
even after over 50 years of research. Continued advancements in ligand design may allow 
for further development for selective catalysts, though developments in other fields such as 
biocatalysis (see below) may eclipse this work. 
 
 
Scheme 8: Systems used for 3o hydroxylation. (a no H2O2 or AcOH). 
52,54,55,56,57,58 
 
2. Enzymatic Oxidation 
 
Over billions of years nature has evolved its biosynthetic technology to catalyze difficult 
reactions. Much of the present research in oxidation catalysis has been inspired by naturally 
occurring metalloenzymes, which predominately employ iron or copper ions within their 
active sites.2 Nature has explored the use of proteins as macromolecular ligands successfully 
outperforming the low molecular weight iron complexes used by chemists. There is a wide 
range of different enzyme types that are known to catalyze oxidation reactions.59 As well, 
they have the advantage of being able to utilize molecular oxygen, the ‘greenest oxidant’, 
efficiently under mild reaction conditions. Metalloenzyme catalyzed oxidations often 
demonstrate high substrate specificity alongside high levels of enantio- and 
regioselectivity.60 Naturally occurring enzymes have been shown to perform oxidative 
reactions including hydroxylation, dihydroxylation of aromatic and aliphatic C-H bonds, 
epoxidation, heteroatom oxidation, Baeyer-Villiger oxidation of ketones to lactones, and 
halohydrin formation from alkenes.61  
 
Enzymatic oxidation reactions have emerged on an industrial scale.64 For example, the 
oxidation of D-glucose to D-gluconolactone using the enzyme glucose oxidase (GO) has been 
used in the food and wine industry (Scheme 9a).62 Another example is the production of 
hydroxy amino acids using L-isoleucine dioxygenase (IDO) (Scheme 9b).63 Hydroxy amino 
acids are promising compounds for drugs and functional foods due to antidiabetes activity. 
The GO and IDO examples are interesting because these utilise the wild type enzymes 
whereas a significant number of current examples of industrial applications use designed 
mutants.  More recent examples have appeared in medicinal chemistry. These include the 
use of a mutant monoamine oxidase in the production of cyclic imine intermediates for the 
synthesis of telapravir, a pharmaceutical drug used for the treatment of hepatitis C (Scheme 
9c).64 
 
 
Scheme 9: a) Oxidation of D-glucose,62 b) Production of hydroxyl amino acids,63 c) 
Synthesis of telapravir. (αKG = alphaketoglutarate, KPi = potassium phosphate buffer).64 
 
However, there are still significant limitations to the application of enzymes in an industrial 
scale processes.65 The most crucial are enzyme stability and productivity. Advances in 
protein engineering provide a vast range of methods to tailor biocatalysts to overcome 
these limitations. Summarised below are the major classes of oxidative enzymes and 
examples are given where bioengineering has led to extraordinary results.  
 
a) 
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Figure 3: Diagrams to represent the different Iron containing active sites found within 
nature a) P450 Heme Active Site (PDB 1JPZ) b) 2-His-1-carboxlate facial triad motif, 
His(Green) Asp (Blue) Water (Yellow) (PDB 1RXF) c) [2Fe-2S] Cluster (PDB 1UUW) d) Di-
iron center seen in monooxygenases Glu (Orange) His (Green) Water (Yellow) (PDB 1MTY) 
 
2.1 Heme Containing Oxidative Enzymes 
 
Heme containing enzymes are one of the most studied classes of oxidative enzymes; 
examples within this family are peroxidases, catalases and P450s. These redox enzymes can 
be used to activate hydrogen peroxide or molecular oxygen, and transfer oxygen to the 
substrate via high-valent iron-oxo intermediates (Scheme 10).66 The active site comprises of 
a porphyrin ring anchored to the protein backbone through a histidine or cysteine residue 
(Figure 3a)67  and held in place via ionic, van der Waals and hydrogen bonding interactions. 
An important intermediate of the heme enzyme’s catalytic cycle is Compound I, an 
oxoiron(IV) porphyrin π cation radical, which has the ability to oxidize a variety of 
substrates, a factor often exploited in biomimetic approaches to oxidative catalysis.68,69  
 
Scheme 10: The P450 catalytic cycle highlighting important intermediates. Centre of cycle 
indicates the active site with a conserved threonine and cysteine. 
 
The most extensively studied type of heme containing enzymes is the cytochrome P450 
family.70,71,72 Cytochrome P450s are a wide family of oxidative enzymes that play a role in a 
diverse span of processes. Some of the most significant reactions catalyzed by P450s are 
monooxygenation of aliphatic and aryl C-H bonds, alkene epoxidation and sulfoxidation. The 
potential of P450s to catalyze the oxidation of unactivated C-H bonds under mild conditions 
using molecular oxygen make this family of enzymes attractive from a synthetic point of 
view.73 Although the complexity of P450s creates limitations in utilizing these enzymes for in 
industrial contexts or for non-native transformations, progress has been made to tune the 
reactivity of these enzymes and to expand their substrate scope.73  
 
Key advances in DNA and gene synthesis have provided a vast range of methods to tailor 
biocatalysts by protein engineering and design. These advances occur via rational, 
semirational or even evolutionary approaches. Examples lie in the areas of directed 
evolution, bioinformatics tools (e.g. multiple sequence alignments and BLAST), 
computational modelling screening and gene shuffling.74,75 In some cases metabolic 
pathway engineering can also be used to disable the pathways to unwanted products. 
P450BM3 and P450cam are naturally occurring enzymes that represent major targets for 
engineering due to their high catalytic activity, high solubility, high expression in Escherichia 
coli, and available structural information on their monooxygenase components.76 P450BM3 is 
the first identified self-sufficient P450, composed of P450 monooxygenase and an NADPH 
diflavin reductase (NADP+ = Nicotinamide adenine dinucleotide phosphate, NADPH = 
reduced form of NADP+). 
 
Bioengineering of P450s has been used to generate enzymes that showed impressive 
regioselectivities in alkane oxidation.  The selective oxidation of n-octane has been achieved 
by the P450BM3 mutant 77-9H which was obtained by directed evolution (Scheme 11a). This 
enzyme gave rise to 52% selectivity for the terminal position, while typically the wild type 
P450BM3 enzymes show less than 10% selectivity for 1-octanol.  The regioselectivity was 
shown to be octane specific as this high level of selectivity was not seen with other 
hydrocarbon chain lengths.77 The same authors have also targeted the hydroxylation of 
more complex target molecules,78,79 as well as epoxidation,80 utilizing the chirality in the 
protein scaffold to give rise to enantioselective transformations (Scheme 11b and c). The 
P450 mutants changed the proteins’ active site in particular ways, for example the F87A 
mutation in P450BM3 9-10A carves out a space in the active site to allow a wider range of 
substrates to bind.78 
 
 
Scheme 11: a) Hydroxylation of Octane using P450BM3 77-9H,
77 b) Enantioselective 
Epoxidation of Terminal Alkenes Scheme,80 c) Oxidation of α–aryl-acetic acid esters.78 (TTN 
= total turnover number). 
 
Regioselective and enantioselective hydroxylation of the C2 position of n-alkanes has been 
achieved using the sextuple mutant P450pyrSM1. n-Octane was hydroxylated exclusively 
(>99%) at the C2 position with 98% ee.81 The P450pyrSM1 mutant is the first enzyme to 
show this high regioselectivity in alkane hydroxylation (Scheme 11a). In a similar way, 
another sextuple mutant P450pyrSM2 hydroxylated propylbenzene with 95% ee and 98% 
selectivity to give almost exclusively (S)-1-phenyl-2-propanol.81  
 
One limitation of using P450s for alkane oxidation is that the P450 binding pocket is 
significantly larger than small chain alkanes, so the binding constant of these alkanes is 
probably too low to bring them into the correct orientation for rapid oxidation to occur. An 
elegant approach to tackle this issue and control the substrate binding employs wild type 
P450BM3 in the presence of chemically inert perfluorinated carboxylic acids (Scheme 12).
82 
Computational studies suggested that the high turnover was attributable to the 
perfluorinated decanoic acid occupying the optimum volume in an apolar binding pocket 
(Scheme 12).  
 
 
 
 
 
 
 
 
 
 
 
Scheme 12: Activator based strategy for modulating P450 reactivity using perfluoro 
carboxylic acids, turnover numbers for variety of hydrocarbon oxidation reactions given.82  
 
 
2.2 Non-heme Iron Oxidative Enzymes  
 
Monooxygenases are a widely studied class of non-heme iron enzymes, they catalyze the 
selective oxidation of a variety of substrates depending on the subtype of enzymes. In all 
cases they use molecular oxygen as the oxidant.83  Several of these enzymes are of 
particular interest for potential chemical applications and will be discussed below. 
 
Methane monooxygenases (MMOs), of which soluble MMO (sMMO) is the most widely 
studied and understood, catalyze the selective oxidation of methane to methanol.  sMMO is 
a three subunit system in which the active site contains a non-heme diiron centre (Figure 
3d). Oxidation of methane using oxygen occurs at a carboxylate-bridged diiron centre of the 
enzyme’s active site in the α-subunit of the enzyme. This subunit is a hydroxylase known as 
MMOH. The other two subunits are a reductase and a coupling protein. To enable efficient 
catalysis all three components are needed, though the MMOH subunit has the capability to 
activate dioxygen by itself.84 
 
The most inert of all alkanes (methane) is readily oxidised to methanol by methane 
monooxygenases (MMO’s). Additionally, the substrate scope of wild type sMMO includes 
 
 
 
 
 
  
 
  
both branched and linear alkanes and tolerates alkene chains up to eight carbons, along 
with aromatic, heterocyclic and chlorinated compounds.83 The application of sMMO on 
large scale seems unlikely as these enzymes are usually multicomponent enzymes and 
recombinant production is problematic. They are also often unstable and prone to product 
inhibition causing low levels of productivity.85 
 
A class of monooxygenases that has found use within the pharmaceutical industry are the 
Baeyer-Villiger monooxygenases (BVMO), which are capable of oxidation of both linear and 
cyclic ketones to esters and lactones using molecular oxygen. BVMOs have been applied 
within microbes, as enzyme extracts and as recombinant enzymes in organic synthesis.86 
Several reviews have appeared in recent years describing the use of BVMOs in organic 
reactions such as steroid transformations, degradation of ketones, heteroatom oxidation, 
aldehyde oxidation and epoxidation.87,88 However, these reactions are complicated due to 
the need for regeneration and retention of the flavin cofactor.87 Significant progress has 
been made in co-factor recycling by continuous substrate feeding, resins and using biphasic 
reactions. A recently developed example involved protein engineering on a BVMO to invert 
the enantioselectivity and improve the activity, stability and chemoselectivity of the 
enzyme. This novel BVMO catalyzes a sulfoxidation reaction to give enantiomerically pure 
esomeprazole (Scheme 13).85,89 Nevertheless, more progress is needed on improving the 
stability and efficiency of BVMO enzymes for their effective use within organic synthesis.    
 
 
Scheme 13: BVMO sulfoxidation to synthesise Esomeprazole.81 
 
Rieske non-heme iron oxygenases (RO) catalyze stereo- and regiospecific reactions and are 
known to catalyze the generation of cis-dihydroxylated metabolites (a common first step in 
bacterial degradation of many aromatic compounds).90 RO enzymes have the ability to carry 
out additional oxidation reactions; some of these include oxidative ring closure, 
desaturation, oxidative catechol cleavage, oxidation of anilines and arene-cis-hydroxylation 
(Scheme 14).91 
 
Scheme 14: Examples of reactions catalyzed by different RO enzymes.91,93 
 
Rieske proteins contain a multicomponent iron-sulfur cluster (Fig. 3c), in which the [2Fe-2S] 
cluster transfers an electron from either the ferredoxin or the reductase component to the 
mononuclear iron for catalytic reactions. The mononuclear iron(II) centre acts as the active 
site of oxidation and is bound in a 2-His-1-carboxylate facial triad motif (Figure 3b). This 
motif is found commonly throughout non-heme iron enzymes. Coordination at this site 
exposes the iron to the large hydrophobic active site, where oxygen can bind and thus 
allows it to interact with the substrate permitting the reaction to occur.92 This trigonal unit 
is often used as inspiration for biomimetic work (see Section 3.2) because it allows these 
enzymes to catalyze more complex reactions in comparison to heme enzymes. Progress with 
RO enzymes in comparison to other enzyme groups has been limited due to the lack of 
structural data until fairly recently.93 
 
 
2.3 Copper Containing Oxidative Enzymes 
 
Similar to the iron containing enzymes, copper containing oxidases and oxygenases bind and 
activate oxygen to oxidize organic substrates. The active sites within these copper 
containing enzymes contain a varied number of copper ions. Laccases are the largest 
subgroup of blue multicopper oxidases (MCO). They have the capability to catalyze the 
oxidation of various aromatic substrates including ortho- and para-diphenols, 
aminophenols, polyphenols, polyamines, aryl diamines, and inorganic ions.94 They contain 
four copper atoms in the active site, which are organized into three different copper centres 
(Figure 4).95 Most substrates used by laccase enzymes are phenols with redox potentials 
similar to that of the laccase itself, hence their ability to reduce the T1 centre.96  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Laccase Active Site (PDB 25HU) illustrating the trinuclear cluster (TNC) of copper 
atoms and the single copper atom known as a T1 site (His in blue, Cys in green). 
 
Laccase proteins are able to maintain stability at 60 °C, which is beneficial for large-scale 
applications. However, they have narrow substrate specificity and the enzyme is difficult to 
recycle. The redox potential of laccases prevents the enzyme from oxidizing primary 
alcohols but a biphasic system of laccase with a chemical mediator, TEMPO, has been 
successfully developed for this reaction.97 This system has the advantage that TEMPO is 
regenerated by the laccase, and therefore the methodology is not restricted by the 
substrate selectivity of the enzyme.98 The laccase/TEMPO system has been shown to oxidize 
the primary hydroxyl group in monosaccharides and natural glycosides to acids under mild 
conditions (Scheme 15a and b).99 A laccase/TEMPO system was applied for the formation of 
C-C bonds via an aldol addition, involving the in situ generation of the acceptor aldehyde 
(Scheme 15c).98 
 
Scheme 15: Laccase catalysed oxidation of a) a monosaccharide,99 b) Amygdalin99 and c) 
an acceptor aldehyde.98 
 
Galactose oxidase (GAO) is a well-studied radical copper oxidase that uses an unusual 
copper (II)-tyrosyl radical unit to undergo two electron redox chemistry for the oxidation of 
alcohols to aldehydes.100 The native enzyme has a relatively narrow substrate scope only 
oxidizing D-galactose to D-galacto-hexodialdose. Using directed evolution methods, 
galactose oxidase has been engineered for the kinetic resolution of secondary alcohols. (R)-
enantiomers were oxidized with up to 50% conversion and the remaining (S)-substrates 
were obtained in 99% ee.101 
 
3. Design strategies towards selective oxidation 
 
In the sections above we have highlighted examples of successful chemical and enzymatic 
approaches to oxidative transformations. Behind these examples, a wide variety of design 
strategies have been utilized to improve the selectivity and activity of catalysts for oxidation 
reactions.   
 
3.1 From empirical methods to ligand design 
Early oxidation reactions were initially developed on an empirical basis, employing reagents 
known to be powerful oxidizing agents. Trial and error along with mechanistic 
understanding gave rise to a variety of successful stoichiometric oxidants that are still 
routinely employed in research labs around the world, such as NaClO4, mCPBA, oxalyl 
chloride (Swern Oxidation), Dess-Martin periodinane, and TEMPO.11 However, the drive 
towards more environmentally benign procedures in the chemical industries has seen the 
implementation of catalytic methodologies. The use of NMO to regenerate the oxidant 
serves as an effective method of minimising the quantities of oxidant from stoichiometric to 
catalytic, and has been used in the Ley-Griffith oxidation and Upjohn dihydroxylations. 
Whilst the use of NMO to generate catalytic methodology is useful for application in alcohol 
oxidation, it is less useful in enantioselective reactions such as sulfoxidation, epoxidation 
and dihydroxylation.  
 
Among others, the developments of the Noyori, Knowles, Sharpless and Jacobsen catalysts 
led to the huge rise in rational ligand design.102 The Jacobsen epoxidation represents an 
early example of the possibilities of designing ligands that can impart predictable selectivity 
upon a given substrate. To overcome the challenge of epoxidizing unfunctionalised alkenes 
Katsuki28 and Jacobsen103 independently arrived at chiral Mn(III) salen catalysts. Both 
systems used steric bulk on the aryl groups to affect enantioselectivity, through obstructing 
the approach of one face of the alkene over the other. This built on the concept of 
‘quadrants’, namely, that the approach of a substrate to a reactive metal centre can be 
simplified to two of four open ‘quadrants’. The other two quadrants are ‘closed off’ to 
approach by steric bulk, which gives rise to a powerful method for preparing and optimising 
asymmetric catalysts (Figure 5). Continuing fine tuning of ligand design and greater 
understanding of reaction mechanisms has led to a number of privileged chiral ligands, 
including the salen (see 5, Figure 1) and cinchona ligand classes (see 10, Scheme 6) used in 
asymmetric epoxidation, dihydroxylation and sulfoxidation.104 The rational design of ligands 
has been very successful in the field of asymmetric catalysis, though often the rational used 
for the design is challenged by subsequent results. Without increasing understanding of 
reaction mechanism and all the factors affecting reaction outcomes, chances of successful 
ligand design may become small. 
 
Figure 5: Quadrant concept as exemplified by the Jacobsen catalysts. 
 
3.2 Biomimetic and bioinspired approaches 
The way nature addresses the challenge of oxidation provides an inspiration and a starting 
point for the synthetic chemist. The study of enzymes has led to biomimetic design 
approaches in which the first coordination sphere of a metalloenzyme is mimicked using 
ligand design.105,106 The enzymes most often used for inspiration are cytochrome P450s, 
sMMO and Rieske dioxygenases (see section 2, Figures 3 for illustrations of their active 
sites). These enzymes are able to carry out highly selective oxidations, however, their 
substrate scope can be narrow, and several issues hinder their use in the chemical 
industries, including the need for complex co-factors and their instability towards harsh 
reaction conditions.  
 
Biomimetic work aims to provide a greater understanding of the mechanism of oxidation 
reactions both in nature and in the laboratory. In a number of cases the intermediates in 
oxidation reactions have not been isolated and the mechanism of these systems is still the 
source of controversy. For example, since Fenton’s observation that simple iron salts 
oxidized samples of tartrate in the presence of H2O2, the exact nature of the reaction has 
been debated.107,108,109 It is generally accepted that ‘Fenton chemistry’ operates via the 
generation of extremely reactive hydroxyl radicals.110 This makes selective C-H oxidation 
extremely difficult, as H radicals will be abstracted indiscriminately and with little control 
over the extent of oxidation, giving poor regio- and chemoselectivity.111 In contrast, Barton’s 
‘Gif’ system is commonly held to proceed via a high-valent metal-oxo intermediate involving 
C-H abstraction quickly followed by ‘oxygen rebound’, as evidenced by its unusual reactivity 
and the lack of mechanistic evidence for radicals.112 The proposed mechanism bears strong 
similarities to the ‘push-pull’ concept proposed for P450s (Scheme 10), and is an elegant 
example of how biological understanding can enhance and direct chemical design. 113 
 
Early biomimetic work focused on metalloporphyrins due to a greater understanding of the 
mechanism of heme proteins compared to others at that time.  This led to these systems 
being among the first exploited in bioinspired organic synthesis focusing on oxidation 
chemistry.114 Early examples included epoxidation and some of the first reported alkane 
oxidation catalysts.115 Later development of porphyrin based catalysts concentrated heavily 
on restricting the conformational flexibility of the substrate (discussed in 3.3), and 
developing asymmetric catalysts. These catalysts have been used in asymmetric C-H 
hydroxylation and epoxidation, albeit with limited substrate scope and high variability in 
yield and ee (see Table 1).116 These limitations, alongside the synthetic challenges in 
preparing these catalysts, prevent these systems from reaching mainstream synthetic 
applications and have led to the focus switching to non-heme inspired systems in recent 
years.117,6  
 
Table 1: C-H activation using ruthenium porphyrin catalysis.116  
 
Attempts have also been made to mimic the intriguing diiron center of sMMO to gain a 
better understanding of the enzyme’s mode of action, and to develop novel synthetic 
catalysts. This work has centred on the use of carboxylate or N-ligands such as tris(2-
pyridylmethyl) amine (TPA) with dinuclear metal cores. Disappointingly, the mimics 
reported thus far often show only low levels of oxidation activity and have not led to a 
synthetically useful methodology. However, these structural mimics (Figure 6)118 have been 
highly influential in determining the nature of the active species and providing mechanistic 
details of oxidation using MMOs.119,120  
  
Figure 6: a) Intermediate Q from the catalytic cycle of sMMO119 and mimics of 
intermediate Q: b) derived from dicarboxylate ligands121 and c) derived from TPA 
derivatives.119 
 
More recent work has therefore focused on the active sites of Rieske dioxygenases (Figure 
3b) and its 2-His-1-carboxlate facial triad motif. This has led to a diverse range of bioinspired 
oxidation catalysts being reported. Early examples appeared from Que and co-workers, who 
in 1997 reported TPA iron complexes capable of regio-selective alkane oxidation.122 The best 
performing non-heme ligands are typically tetradentate nitrogen donors, as illustrated by 
the novel catalysts reported in the groups of Britovsek,123 Costas,54 White,52 and 
Goldsmith.124  
 
As part of their work on biomimetic oxidation, Que and co-workers conducted detailed 
investigations into the TPA ligand class. They demonstrated mechanistic evidence of a high 
valence, non-heme iron oxo species believed to effect oxygen transfer.51 Later, they 
established that the outcome of a non-heme iron catalyzed oxidation of a given alkene 
(epoxidation vs. dihydroxylation) was highly dependent upon the ability of the initially 
formed iron(III) centre to maintain a low spin configuration (Scheme 16).125 Increased steric 
bulk at the α-pyridyl position (18 and 20 vs 17 and 19) was suggested to increase preference 
for a high spin iron(III) intermediate, which led to dihydroxylation becoming the favoured 
outcome. Subsequent work by Costas and co-workers showed that the electron donating 
properties of para-pyridyl substituents had a direct influence on enantioselectivity in the 
epoxidation of conjugated alkenes.126  
 
 
 Scheme 16: The influence of N-pyridyl substituents on diol:epoxide ratios.125 
 
One of the features of both the sMMO and Rieske dioxygenase enzymes is the presence of 
carboxylate ligands in the first coordination sphere. The above work has focused on 
nitrogen donor ligands, though in a number of cases carboxylic acid additives are found to 
play a key role in enhancing selectivity and activity. Recent mechanistic studies provide a 
putative explanation for the role of carboxylic acids in accelerating these reactions, 
producing EPR evidence of an acylperoxo iron(III) species which promotes O-O bond 
cleavage. This has further guided the optimization of these processes.127,128 Mechanistic 
studies also suggest that the oxygenation step occurs in a concerted fashion from a metal 
oxo species, as the stereochemistry was completely retained in these reactions, with 91% 
incorporation of 18O from radiolabelled H2
18O2.
129 
 
Some heterogeneous catalysts, like enzymes, exploit the concept of encapsulating the 
substrate in a defined macroscopic environment. We will discuss shape selective 
approaches in the next section. In some cases, structural motifs direct from nature such as 
metalloporphyrins have been combined with macroscopic heterogeneous scaffolds to make 
use of their reactivity. Micro- and mesoporous frameworks consisting of iron porphyrins 
delivered extraordinary turnover numbers of over 97,000 in the oxidation of thioanisole 
under ambient temperature and atmospheric pressure with O2 as the oxidant (Scheme 
17).130 When the catalyst was tested across a wider range of substrates under similar 
conditions, both product selectivity for the sulfoxide over the sulfone (99:1) and activity 
were retained.130 Heterogeneous material made from amino acids is another bioinspired 
approach. L-leucine polymers capped with phosphonates for titanium coordination were 
effective (up to 99%) for enantioselective formation of styrene glycol from racemic styrene 
oxide.131 Additionally, a similar L-phenylglycine based material was successfully employed 
for the epoxidation and hydration of styrene, the latter with excellent enantioselectivity 
(>99%).132 
 
Scheme 17: Cross linked porphyrins employed for catalytic sulfoxidation (value in brackets 
gives product selectivity for the sulfoxide over sulfone).130 
 
  
3.3 Shape selective approaches 
One of the most important aspects of enzymes responsible for their selectivity is the 
influence of the secondary coordination sphere on substrate binding and orientation. In 
Section 2 we have seen examples of how this can be modified in enzymes either by 
mutation or the use of additives such as perfluorinated carboxylic acids. An alternative way 
to improve reaction selectivity with chemical catalysis is to use shape selective approaches.3 
An early design concept based upon this was the so-called ‘picket fence’ idea postulated by 
Collman (Figure 7). This focused on restricting the conformational flexibility of the substrate 
at the porphyrin based catalytic centre. This would serve to direct selectivity in favour of 
sterically less hindered sites, as well as minimise catalyst deactivation by the formation of 
oxo-bridged dimers. This approach was employed throughout the 1980s and early 1990s in 
several groups, including those of Groves,133 Nam,134 Khenkin,135 Suslick136 and Mansuy.137 
One of the more promising examples of these so-called ‘bis pocket’ porphyrins was 
tetrakis(triphenylpheny)l porphyrin (TTPPP, Figure 7), which gave some of the best 
regioselectivities known at the time for linear alkanes (21:48:16:15 for C-1:2:3:4 in the 
hydroxylation of n-octane).136 By anchoring a manganese porphyrin to four cyclodextrin 
moieties, Breslow and co-workers achieved 73% conversion, and 100% selectivity for the 
hydroxylation of C-7 of a steroid (Figure 7).138  
 
Figure 7: Porphyrins designed on the ‘picket fence’ concept. 
A common feature of catalyst systems such as these, however, is that regioselectivity is 
generally found to be dependent upon the length of the alkane substrate.136 This is 
indicative of a lack of control over the conformational flexibility of the substrate at the 
metal centre, which can be overcome using heterogeneous systems.139 Alongside offering 
more rigid systems, porous materials such as zeolites withstand harsher reaction conditions 
and are therefore less susceptible to degradation under oxidizing conditions.140 Tolman 
elegantly showed this with a Fe-Pd zeolite, which operated via supposedly ‘unselective’ 
Fenton chemistry, yet showed excellent primary C-H selectivity (0.67 primary vs. secondary 
C-H) in the oxidation of linear alkane, superior to the best homogeneous catalysts at the 
time.139 Moreover, this selectivity was preserved irrespective of alkane chain length, and in 
the presence of a competitive cyclic substrate (cyclohexane). This is in contrast to the bis 
pocket porphyrins.139 Thomas and co-workers reported utilizing molecular sieves 
impregnated with cobalt and manganese to achieve primary C-H selectivity of up to 0.32 in 
the oxidation of n-octane.141  
 
A zeolite catalyst consisting of osmium(0) clusters encapsulated in zeolites carried out syn- 
dihydroxylation across a broad range of alkenes in yields of up to 98% (Scheme 18a).142 
Selectivity was seen for substrates of certain sizes depending on the zeolite pore size. For 
example, trans-stilbene could be hydroxylated in high yields, but cis-stilbene is too large to 
enter the pores and therefore could only be oxidized on the surface sites giving a reduced 
yield (Scheme 18b). The use of metal-organic frameworks (MOFs) allows chiral metal 
centers to be inserted into a heterogenous framework. Through changing the metal linkers 
the pore size can be modified (1.4 nm to 3.2 nm), leading to rates of reaction equivalent to 
homogenous catalysts for the larger MOFs.143 The enantioselectivities were similar to those 
obtained with the free ligand, 22d. The heterogeneous approach does however suffer from 
the harsh temperatures and pressures employed, and the use of O2 at such pressures does 
present safety concerns.  
 
 
Scheme 18: a) Dihydroxylation using osmium impregnated Zeolite,142 b) Manganese salen 
MOFs.143 (DMF = dimethylformamide, DEF = diethylformamide). 
 
4. Design, synthesis and application of artificial metalloenzyme hybrid catalysts for 
oxidation reactions 
 
Despite the wide array of design principles and optimization tools at our disposal both in 
chemistry and biology, numerous challenges still remain to be solved. This includes highly 
selective catalysts at industrially viable activities across a broad range of substrate scope 
and utilizing mild conditions (e.g. oxygen as the oxidant). Alkane oxidation in particular is 
still in its infancy. Chemical based approaches using small molecule catalysts, whilst 
extremely successful in many fields, has not provided answers to some of the great chemical 
challenges such as alkane oxidation despite 50 years of research. Biocatalysis may provide 
one answer, though their reactions are limited to those employing bioavailable metals, and 
industrialization still poses numerous challenges. We have seen above how mutations to 
enzymes have allowed chemists to increase the substrate scope and tolerance of reactions, 
as well as unlocking new reaction pathways. In the long term the ultimate aim would be to 
utilize any substrate of choice, and to design and synthesize the required catalyst for the 
desired chemical transformation. As such, new catalyst design concepts are still required for 
oxidation of substrates that demand specific chemo-, regio- and enantioselectivity or a 
combination of these. One avenue of exploration lies in the development of hybrid catalysts 
which take the best from nature (use of oxygen, high activities and substrate specificity) and 
synthetic chemistry (broad substrate scope, non-natural activities).  
 
Catalysts that have been designed by using templates and scaffolds provided by nature offer 
many possibilities for tackling such selectivity problems, as they are intensively studied and 
advanced engineering tools are available. A wide range of new catalysts can be synthesized 
by combining "unnatural" metal centres within protein environments yielding artificial 
metalloenzymes. A chemogenetic approach allows for the application of the full plethora of 
chemical and biochemical techniques for optimization of these catalysts.144,145,146 This 
means that for a given transition metal chosen on the basis of activity, two levels of 
optimization can be envisioned. The first level is the optimization of the first coordination 
sphere by the incorporation of an artificial metal binding site via site-directed mutation in 
an enzyme binding site or by introduction of synthetic cofactors. The second level is by fine-
tuning the protein scaffold using protein engineering tools such as mutagenesis or directed 
evolution to allow for optimal substrate binding and orientation leading to enhanced rates 
and selectivities (Figure 8). 
 
 
Figure 8: Concept of artificial metalloenzymes and opportunities for catalyst optimization. 
 
There are several approaches for the design and synthesis of artificial metalloenzymes for 
chemical transformations not performed by natural enzymes.60,144,146,147 Since the 
pioneering work of Kaiser and Whitesides in the 1970s on the synthesis of such hybrid 
catalysts,148,149  the design, synthesis and application of artificial metalloenzymes has made 
impressive progress.150,151 The many different design strategies of these hybrid catalysts can 
be categorized into dative association, supramolecular anchoring, and covalent 
modification. Dative association relates to the introduction of a non-native active metal into 
the protein via native amino acid residues present in a metalloezyme binding site, or via 
amino acids introduced by mutagenesis of an existing protein with the desired structural 
characteristics. Supramolecular anchoring involves making use of the natural affinity of a 
selected protein for a cofactor that can be synthetically modified with a transition metal 
binding site. An example is exploitation of the strong interaction between biotin and 
(strept)avidin (dissociation constant in the order of 10-14 M) to create artificial 
metalloenzymes by application of transition metal-modified biotin molecules.152 The 
covalent modification of protein structures is performed by site selective modification of the 
protein with a transition metal complex, for example by making use a nucleophilic amino 
acid residue. Protein hosts can be selected based on desired characteristics such as 
substrate binding, stability and shape of the binding site.  This approach is not limited to 
using natural occurring proteins as hosts, as demonstrated by Harada et al. who raised 
monoclonal antibodies for a rhodium diphosphine complex. Highly enantioselective 
hydrogenation catalysts were obtained by combining such an antibody with the host 
complex.153 Additionally, de novo design allows for the design of completely new protein 
structures with desired characteristics based on ever evolving modelling software.154,155 
Moreover, the design is not limited to proteins. Other structurally defined biopolymers such 
as DNA156,157,158 have also been utilized. Several elegant approaches for the design and 
application of artificial hybrid oxidation catalysts are highlighted below based on the type of 
oxidation reactions performed. 
 
4.1. Alcohol oxidation 
 
Several elegant bioinspired innovations for the oxidation of alcohols have been reported 
using hydrogen transfer pathways,159,160,161 but the application of artificial metalloenzyme 
catalysts is rarer. One of the earliest reports on artificial metalloenzymes demonstrated the 
oxidation of ascorbic acid to dehydroascorbic acid.149 Since then, only a few examples have 
been reported. Hybrid catalysts based on streptavidin and avidin have been developed using 
a supramolecular anchoring strategy with different ruthenium, iridium and rhodium 
modified biotin complexes and these have been used for the oxidation of 1-phenylethanol 
(Scheme 19).162 Benzyl alcohol and cyclohexanol could also be converted into the 
corresponding aldehyde and ketone respectively (68% and 80% conversion).  
 
Scheme 19: Benzyl alcohol oxidation using ruthenium amino-sulfamide biotin complexes 
anchored via supramolecular interaction to streptavidin.162 
 
Recently, an artificial metalloenzyme for the oxidation of catechol derivatives has been 
designed.163 The zinc in metallo--lactamase from Stenotrophomonas maltophilia can be 
replaced by copper simply by overexpressing the protein in E. coli in the presence of CuSO4. 
Subsequently, a triple mutant was designed based on computer-assisted structural analysis 
of the binding site in order to effectively incorporate a dinuclear copper site. This triple 
mutant contained three strategically placed proximal histidines to achieve this. The 
obtained catalyst system showed a significant rate increase for the oxidation of catechols. 
 
4.2. Sulfoxidation 
 
Asymmetric sulfoxidation of methyl phenyl sulfide and similar substrates is a benchmark 
reaction for assessment of hybrid oxidation catalysts. The emphasis is typically on obtaining 
enantioselectivity, as this demonstrates the influence of chiral environment of the protein 
host on the reaction. Ward and co-workers created a highly selective catalyst system for this 
reaction reaching up to 93% ee for naphthalene methyl sulfide using tert-butyl 
hydroperoxide as oxidant. They employed the dative approach incorporating a vanadyl ion 
in the biotin binding site of streptavidin (Scheme 20a).164 They reasoned that the hydrogen 
bonds that allow biotin to bind strongly are perfectly suited for coordinating the vanadyl ion 
while the hydrophobic residues involved in biotin binding are left free for substrate 
interactions.  The choice of oxidant also appeared important for the selectivity in the 
reaction, as hydrogen peroxide gave no enantioselectivity while cumene hydroperoxide 
provided low enantioselectivity towards the opposite enantiomer. 
 
Many more examples of artificial metalloenzymes for the (asymmetric) sulfoxidation of 
methyl phenyl sulfide and analogues have been reported. Vanadate was combined with 
phytase165 and analogous proteins166 to obtain hybrid catalysts for the same reaction. The 
group of Ward attempted to create enantioselective artificial metalloenzymes for the 
oxidation of methyl phenyl sulfide by anchoring a biotin-manganese salen complexes in 
streptavidin.167 However, these only reached enantioselectivities of up to 13% ee, 
significantly lower than the 46% ee obtained in the same reaction using the vanadyl 
streptavidin described above. Myoglobin anchored managanese and chromium salphen 
complexes have been used to yield up to 30% ee for enantioselective oxidation of methyl 
phenyl sulfide with hydrogen peroxide.168,169 Other examples include the use of Xylanase A 
combined with an iron porphyrin;170 manganese salen complexes supramolecularly 
anchored in human serum albumin;171 and myoglobin in combination with manganese and 
iron porphycene and porphyrins.172 In all cases, once again no improvements in 
enantioselectivity over the vanadyl streptavidin system were obtained, though the latter 
example showed high TOFs (up to 142 mol·mol-1·h-1). Application of the supramolecular 
interaction between antibodies and metal complexes to obtain enantioselective 
sulfoxidation catalysts has also been reported (ee's up to 45% R, and 43% S).173,174,175 
Additionally, covalent anchoring has been applied to combine manganese salphen 
complexes with myoglobin giving up to 60% ee.176,177 
 
 
Scheme 20: (Enantioselective) sulfoxidation by a) complex resulting from the interaction 
of streptavidin with VOSO4
164 b) Supramolecularly anchored manganese corroles into 
serum albumins179 c) Iron-nitrogen complexes supramolecularly anchored in nickel-
binding protein (NiKa).180 
 
 
One advantage of using artificial metalloenzymes is that they can outperform traditional 
catalytic metal centres containing chiral ligands in ease of synthesis, activity and 
enantioselectivity.178 Classic asymmetric ligands for transition metals such as chiral 
manganese and iron corrole complexes can be difficult to synthesize, compared to achiral 
derivatives. Inspired by work that had demonstrated how effective sulfoxidation catalysts 
could be obtained by mixing amphiphilic manganese corroles with serum albumins,179 a 
small library of achiral manganese corroles was applied in combination with a small library 
of proteins. Protein/Mn-corrole combinations were identified that gave the sulfoxide 
product in good yield (up to 71%) and good enantioselectivity (up to 65% ee), outperforming 
the synthetic chiral corrole complexes. Application of this approach combined with further 
optimization of the reaction conditions yielded a good catalyst for the enantioselective 
synthesis of Armodafinil through asymmetric sulfoxidation (Scheme 20b). 
 
One of the challenges in the design of artificial metalloenzymes is gaining structural 
information about the active site and translating that to catalyst improvement. The use of 
crystal structures with docking experiments is one way to identify suitable substrates for 
sulfoxidation. Crystal structures were obtained of a hybrid sulfoxidation catalyst consisting 
of iron-dipyridine-diamine complexes with the periplasmic nickel-binding protein NiKa 
(Scheme 20c).180 These showed that the metal complexes were supramolecularly anchored 
into the binding site via salt bridges and -stacking with arginines and a tryptophan 
respectively.181,182 It was found that when substrates containing an Ar1-S-CH2-CONH-Ar2 
motif are docked into the binding site this results in an ideal Fe-O---S transition state for this 
reaction. Several of these substrates were tested and gave high conversions and showed a 
good relationship between the substrate specificity and results from the docking studies. In 
these systems the protein environment did not seem to induce high stereospecificity as only 
very low enantioselectivity (up to 10% ee) was observed. Sodium perchlorate was essential 
for the activity as other oxidants such as hydrogen peroxide gave no activity. 
 
4.3. C=C and C-H bond oxygenation 
 
Following an early report on artificial metalloenzymes for enantioselective epoxidation of 
alkenes using manganese-salen covalently modified papain,183 several groups have reported 
more selective hybrid catalysts for this reaction. The group of Kazlauskas reported the use of 
carbonic anhydrase in which the native bound zinc ion was replaced by manganese.184  
Enantioselectivities of up to 67% ee were reported for the epoxidation of styrene derivatives 
using a mixture of hydrogen peroxide with hydrogen carbonate buffer, which is postulated 
to generate peroxymonocarbonate (HCO4
-) in situ. Other substrates, like trans--
methylstyrene and aliphatic alkenes, were epoxidized with moderate enantioselectivity. 
However, a very low TON (up to 10 mol substrate/mol catalyst) was observed. Importantly 
no aldehyde side products were observed. Similar results for the epoxidation of alkenes 
using a nearly identical catalytic system have been reported.185  
 
The group of Mahy reported artificial heme containing enzymes which are able to oxidise 
guaiacol and o-dianiside with hydrogen peroxide.186  These were prepared from Xylanase A, 
an enzyme that is commercially applied in the hydrolysis of xylan and therefore readily 
available. The same group associated manganese porphyrins into Xylanase A for the 
epoxidation of styrene derivatives using potassium peroxymonosulfate (Scheme 21).187 With 
this catalytic system low enantioselectivity was found for the epoxidation of styrene (8.5% 
ee). However, p-methoxystyrene gave good enantioselecitivty (80% ee). Conversion was low 
(up to 17%) but higher compared to hybrid catalyst systems described earlier in this section.  
 
 
Scheme 21: Enantioselective alkene epoxidation using Mn-porphyrins supramolecularly 
anchored into Xylanase 10A.187 
 
High conversion for the epoxidation of styrene derivatives (up to 93%) with an artificial 
metalloprotein was accomplished by covalently modifying a unique cysteine in nitrobindin, a 
hemebinding protein with a large hydrophobic cavity, with a maleimide containing 
manganese terpyridine cofactor (Scheme 22a).188 Using peroxyacetic acid in phosphate 
buffer, high epoxide yields were obtained at low temperature. However, only a minimal 
preference for one of the enantiomers was reported (er 53.5:46.5). Benzylic C-H bonds 
could be oxidized to the corresponding ketones using the same catalytic system and 
conditions (Scheme 22b). Additionally, oxidation of cyclohexyl methyl ether was performed 
to obtain cyclohexanone via ethereal -C-H oxidation followed by hemiacetal 
decomposition using the same catalyst and reaction conditions (Scheme 22c). Hayashi and 
co-workers incorporated manganese porphycene into myoglobin and the obtained artificial 
metalloenzymes were able to selectively oxidize ethylbenzene to 1-phenylethanol with 
hydrogen peroxide.172 They showed using kinetic isotope effects that hydrogen abstraction 
from the substrate is the likely rate determining step and that the C-H activation partially 
includes an electron transfer process. 
 
Scheme 22: Manganese terpyridine covalently modified nitrobindin188 for a) alkene 
epoxidation with b) benzylic oxidation and c) etheral C-H oxidation. 
 
Asymmetric dihydroxylation of alkenes using artificial metalloenzymes was already reported 
in 1983 by Okano et al.189 They utilized the strong affinity of bovine serum albumin (BSA) for 
metal ions to create an enantioselective cis-hydroxylation catalyst based on osmium 
tetraoxide. A promising 68% ee for the cis-hydroxylation of -methylstyrene was obtained. 
Recently, this early work has been used as the basis for the development of osmium 
tetraoxide-streptavidin based hybrid catalysts for the same reaction (Scheme 23).190 
Streptavidin was demonstrated to be the most effective host protein for OsO4 achieving high 
selectivity and activity for the cis-hydroxylation of -methylstyrene (95% ee R, TON = 27 mol 
substrate/mol K2[OsO2(OH)4]), though BSA also performed well (77% ee S, TON = 4 mol 
substrate/mol K2[OsO2(OH)4]). The enantioselectivity could be improved to 97% ee (R) using 
site directed mutagenesis. Other alkene substrates were also dihydroxylated with good 
enantioselectivity. Remarkably, almost complete inversion of the enantioselectivity could be 
achieved for allyl phenyl ether by two mutations (from 82% S to 77% R).  This is an indication 
of the power of genetic optimisation for these catalytic hybrid systems. Nevertheless, no 
mutations have thus far yielded more active catalysts compared to the wild-type 
streptavidin based catalytic system. 
 
 
Scheme 23: Enantioselective dihydroxylation of alkenes by an artificial metalloenzyme 
created by the dative interaction of streptavidin mutants and OsO4.
190 
 
Natural enzymes are able to catalyze complex cascades of chemical reactions in living cells, 
even in the presence of many other enzyme clusters. This is partly due to efficient 
compartmentalization of the different active sites protecting them from mutual 
deactivation. Being able to mimic such tandem reactions would be highly desirable. One-pot 
combinations of enzyme catalyzed reactions with transition metal catalyzed reactions have 
already been reported191 but the development of such systems is very challenging and only 
a few examples exist which employ artificial metalloenzymes.192 Several such tandem 
reactions, based on an artifical transfer hydrogenase that can act in a cascade with 
enzymatic reactions, have been reported (Scheme 24).193 The artificial transfer hydrogenase 
was assembled by combining the high affinity of streptavidin for biotin with a modified 
iridium-d6-pianostool complex. This resulted in compartmentalization of the hydrogen 
transfer catalyst and the NADH dependent monooxygenase, allowing regeneration of the 
NADH. If the reaction was run without streptavidin, the iridium catalyst was quickly 
deactivited demonstrating the need for compartmentalization.  
 
  
 
Scheme 24: Cascade reaction for the NADH dependent enzymatic hydroxylation of 2-
hydroxybiphenyl coupled to a NADH regeneration process based on an artificial transfer 
hydrogenase (ATHase).193 
 
 
4.4. Other Oxidation reactions 
Site selective cleavage of DNA is an important field where artificial metalloenzymes are 
applied using sequence specific DNA-binding proteins. A recently reported elegant construct 
for oxidative site selective cleavage of DNA makes use of an existing a trimeric ring shaped 
DNA-clamp that is part of bacteriophage T4 replisome (gp45) (Figure 9).194 Covalent 
modification with a manganese porphyrin via a single cysteine, introduced by site-directed 
mutagenesis, gives rise to an enzyme that selectively cleaves one strand of double stranded 
DNA containing three consecutive AT base pairs forming aldehyde residues. The resulting 
aldehydes were visualized with atomic force microscopy by reaction with hydroxylamine 
modified biotin followed by association to streptavidin. Utilization of the clamp showed 
clusters of streptavidin labels on the plasmid. This indicated processive catalytic behaviour, 
meaning the performance of consecutive reactions at the initial binding site. Addition of an 
octapeptide that blocks the clamping behaviour of the trimeric protein resulted in 
disruption of the clamp indicated by the observation of no streptavidin clusters, which leads 
to distributive catalysis.  
 
 
Figure 9: Metalloenzyme construct for site selective single stand cleavage of double 
stranded DNA and subsequent visualization methodology.194 
 
Metalloenzymes designed for site-specific DNA cleavage were also created using unnatural 
amino acids. A bipyridine substituted alanine was introduced into a catabolite activator 
protein. Upon addition of copper, an artificial metalloenzyme was created which could be 
applied in site selective cleavage by sequence specific association of this complex to double 
stranded DNA.195 
 
Figure 10:  a) Surface models of DFsc (DFsinglechain) (top) and G4DFsc (bottom) based on 
the initial computational design. The four Ala to Gly substiturtions (shown in white) open 
the substrate access channel. b) Illustration of the 3-His-G2DFsc variant that highlights the 
added active site His residue (H100) Reprinted with permission from ref197. Copyright 
(2014) Nature Chemistry. 
 
The most challenging aspect of artificial metalloenzymes is the de novo design of peptide-
transition metal catalysts. Several of the examples mentioned above already come close to 
this concept such as site directed mutagenesis guided by rational computer aided active site 
design. An elegant example of this so called de novo design for oxidation catalysts is the 
design of novel ‘Due Ferri’ (DF) diiron complex containing proteins. DeGrado and co-workers 
designed a four-helical bundle containing a diiron binding site consisting of four glutamate 
and two histidine residues.196,197 In order to create an effective phenol oxidation catalyst 
based on the original four-helical bundle four leucine residues were replaced by glycines 
(G4DFsc) to allow better substrate access to the active site (Figure 10). The subsequent 
helical destabilization caused by these mutations was counteracted by further mutations 
aimed at stabilizing the helix. The resulting artificial diiron enzyme was an effective catalyst 
for the oxidation of 3,4-di-tert-butylcatechol and 4-aminophenol. Recently, the same group 
reprogrammed this artificial metalloenzyme to perform N-hydroxylation of activated aryl 
amines.198 The change in activity was achieved via several site-directed mutagenesis steps 
based on rational design and molecular modelling. An additional iron binding histidine was 
introduced based on the active site to mimic a similar active site in p-aminobenzoate N-
oxygenase (AurF). The latter mutation (3His-G2DFsc) resulted in steric clashes necessitating 
two further second-shell mutations and one third-shell mutation. The resulting catalyst 
showed similar hydroxylation activity compared to Aurf with complete loss of hydroquinone 
oxidation activity. 
 
5. Conclusions 
 
Transition metal oxidation catalysts and natural enzymes perform oxidation reactions that 
play a crucial role in chemical synthesis, with many examples of industrial application. Both 
have their distinctive advantages and often they are complementary to one another. In 
addition, enzymes also display high levels of enantio- and regioselectivity. As shown in the 
examples in this review metalloenzyme catalyzed oxidation reactions often demonstrate 
high substrate specificity. Nevertheless, most laboratory scale and many industrial scale 
oxidation reactions are performed using active transition metal salts due to the wide 
number of reactions they catalyze, their activity and ease of use, even though selectivity 
issues mean additional steps (e.g. the introduction of protecting groups) is needed.60 
 
While the naturally occurring enzymes provide many possibilities, there are still many 
limitations to using them on an everyday basis. Enzymes are often superior to synthetic 
catalysts due to highly efficient substrate recognition and orientation leading to selectivity. 
However, they often have limited diversity in reaction and substrate scope, being confined 
to biologically relevant reactions and naturally occurring substrates. Application can often 
be non-trivial due to restraints on reaction conditions, required use of coenzymes and non-
trivial production and purification procedures. Additionally, for many desired oxidative 
transformations there are no enzyme catalysts currently available. Synthetic catalysts have 
the advantage that they possess good activity over a wide span of reactions, but they have 
low selectivity and limited means to differentiate between substrates. Combining these 
catalytic systems is a logical line of research to obtain catalysts that overcome their inherent 
limitations.  
 
In the last decade many reports have been dedicated on the development of methodology 
to create artificial metalloenzymes and for implementation in model reactions, to overcome 
the inherent limitations of both chemical and enzymatic catalysis. These advancements 
were made possible by the increasing understanding of how enzymes function, which has 
been advanced by developments in structural characterization techniques and mechanistic 
studies. As more is known about the enzymes functionality and the influence of the second 
coordination sphere on reactions, an array of interesting starting points to develop the 
naturally found enzymes into ideal catalysts presents themselves. The design of such 
catalysts will be aided by advanced molecular modelling of the active sites to select 
mutations that will give optimal substrate binding or transition state stabilization. 
Additionally, de novo design of novel amino acid scaffolds for assembly of artificial 
metalloenzymes can lead to completely new structural designs. The application of accurate 
structure prediction software is essential for the development of such catalytic systems. The 
demonstration of the application of artificial metalloenzymes in tandem reactions also 
begins to unravel their true potential. Compartmentalized catalysts could provide significant 
advantages over traditional synthetic catalysts. We anticipate these advancements will 
increase the variety of ideal catalysts available for demanding oxidative transformations, as 
well as greatly increasing our knowledge of how enzymes function. 
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